Possible role of exercise therapy on depression: Effector neurotransmitters as key players.
Level 5 - mechanism / opinion, no new human data
Narrative review of biological mechanisms without systematic clinical trial synthesis
PubMed 38048912 · doi:10.1016/j.bbr.2023.114791
What was done
This paper reviewed the neurobiological mechanisms underlying the antidepressant effects of exercise, synthesizing pathways across neurotransmitter systems (serotonin, dopamine, GABA, glutamate, acetylcholine), neuropeptides, myokines (irisin), neurotrophic factors (BDNF, IGF-1), and inflammatory cytokines.
What was found
The abstract reports no empirical numbers or quantitative effect sizes. It qualitatively describes multiple biochemical pathways: exercise increases serotonin levels and receptor sensitivity, enhances dopamine signaling and BDNF/TrkB expression, modulates GABA and glutamate homeostasis via PGC1α, elevates endogenous opioids and irisin, increases the plasma tryptophan-to-competing amino acid ratio, and decreases pro-inflammatory cytokines including TNF-α, IFN-γ, IL-6, and IL-1β.
Why it matters
It provides a consolidated map of the multi-target neurochemical pathways through which physical activity may protect against depression and promote neurogenesis.
Limits
The abstract describes a narrative mechanistic review without primary clinical trial data, systematic search criteria, or quantitative synthesis. Many cited pathways reflect animal or laboratory paradigms, leaving human clinical effect sizes and specific exercise dosing unspecified.
Cited by
- context Aerobic exercise increases serotonin levels in humans.